Health For Each Health For Each
bone cancer cells Employees Health Benefits KFF Health Information KFF Health public health experts HIV President Donald Trump

insulin supplements


Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

In a recent review and meta-analysis published in the International Journal of Obesity, researchers evaluated the safety and efficacy of once-weekly Tirzepatide, a revolutionary new anti-obesity and anti-diabetes drug, against conventional long- and ultra-long-acting insulin supplements in managing type 2 diabetes (T2D).